RECRUITINGPhase 4INTERVENTIONAL
Exparel and Education to Avoid Opioids After Carpal Tunnel Release
About This Trial
This trial seeks to use the long acting local anesthetic Exparel, in conjunction with opioid education, to attempt to avoid any post-operative opioid use following carpal tunnel surgery. This group will be compared with a "standard" group that receives non-liposomal bupivacaine, opioid education, and opioids.
Who May Be Eligible (Plain English)
Who May Qualify:
- carpal tunnel syndrome diagnosed either by physical exam or EMG
- age \>18.
Who Should NOT Join This Trial:
- allergy to bupivacaine
- pre-operative opioid usage within the last six months
- patients allergic to Percocet or acetaminophen
- patients taking tricyclic antidepressants (interaction with bupivacaine)
- vulnerable populations (prisoners or pregnant women)
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* carpal tunnel syndrome diagnosed either by physical exam or EMG
* age \>18.
Exclusion Criteria:
* allergy to bupivacaine
* pre-operative opioid usage within the last six months
* patients allergic to Percocet or acetaminophen
* patients taking tricyclic antidepressants (interaction with bupivacaine)
* vulnerable populations (prisoners or pregnant women)
Treatments Being Tested
DRUG
Differing pain management strategy
The investigators aim to investigate an alternative (vs "standard") pain management strategy for post operative carpal tunnel release. All drugs used are FDA approved for these indications, and no drug itself is being investigated.
Locations (2)
Orthopedic Associates of Southwest Ohio
Dayton, Ohio, United States
Orthopedic Associates of Southwest Ohio
Dayton, Ohio, United States